EUDAW Stock Financials: Financial Performance and Reports

Period	FY-2023	FY-2022	FY-2021	FY-2020
Period Ended	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Operating Revenue	$3.71 M	$9.84 M	$10.54 M	$8.88 M
Cost of Revenue	$2.86 M	$6.49 M	$6.30 M	$4.99 M
Gross Profit	$842,075.00	$3.35 M	$4.24 M	$3.89 M
Gross Profit Ratio	0.23	0.34	0.4	0.44
Research and Development Expenses	$0.00	$17,209.00	$129,265.00	$158,011.00
General & Administrative Expenses	$4.27 M	$7.15 M	$4.08 M	$3.76 M
Selling & Marketing Expenses	$533,562.00	$1.90 M	$1.26 M	$863,389.00
Selling, General & Administrative Expenses	$4.80 M	$9.06 M	$5.34 M	$4.63 M
Other Expenses	$134,584.00	-$12.78 M	$386,828.00	$1.09 M
Operating Expenses	$4.80 M	$9.07 M	$5.47 M	$4.78 M
Cost And Expenses	$7.67 M	$15.56 M	$11.77 M	$9.77 M
Interest Income	$0.00	$120,082.00	$1.92 M	$65,819.00
Interest Expense	$23,225.00	$120,082.00	$127,126.00	$65,819.00
Depreciation & Amortization	$111,200.00	$256,258.00	$650,931.00	$285,378.00
EBITDA	-$3.85 M	-$18.25 M	-$577,296.00	$484,241.00
EBITDA Ratio	-1.04	-1.85	-0.05	0.05
Operating Income	-$3.96 M	-$12.06 M	-$1.23 M	$198,863.00
Operating Income Ratio	-1.07	-1.23	-0.12	0.02
Total Other Income/Expenses Net	-$4.47 M	-$19.09 M	$2.18 M	$47,586.00
Income Before Tax	-$8.43 M	-$24.93 M	$948,537.00	$246,449.00
Income Before Tax Ratio	-2.28	-2.53	0.09	0.03
Income Tax Expense	$1.60 M	$17,422.00	$48,141.00	$47,477.00
Net Income	-$10.04 M	-$24.88 M	$864,829.00	$175,575.00
Net Income Ratio	-2.71	-2.53	0.08	0.02
EPS	-0.44	-2.07	0.0935	0.0087
EPS Diluted	-0.44	-2.07	0.0935	0.0087
Weighted Average Shares Out	$22.90 M	$12.03 M	$9.25 M	$20.19 M
Weighted Average Shares Out Diluted	$22.90 M	$12.03 M	$9.25 M	$20.19 M
Link

EUDA Health Holdings Limited (EUDAW) Financials